Journal of Cancer Therapy
Vol.8 No.9(2017), Paper ID 79016, 11
pages
DOI:10.4236/jct.2017.89072
Clinical Predictors of Cetuximab for First-Line Therapy of Metastatic Colorectal Cancer: A Single Institutional Retrospective Study
Yuki Morishita, Hiroaki Tanioka, Motoi Asano, Kotomi Tokuyama, Hiroko Okamoto, Tomohisa Okamoto, Takako Oda, Masatoshi Ohta, Masayuki Fukuzawa
Department of Pharmacy, Okayama Rosai Hospital, Okayama, Japan
Department of Medical Oncology, Okayama Rosai Hospital, Okayama, Japan
Department of Medical Oncology, Okayama Rosai Hospital, Okayama, Japan
Department of Pharmacy, Okayama Rosai Hospital, Okayama, Japan
Department of Pharmacy, Okayama Rosai Hospital, Okayama, Japan
Department of Pharmacy, Okayama Rosai Hospital, Okayama, Japan
Department of Pharmacy, Okayama Rosai Hospital, Okayama, Japan
Department of Pharmacy, Okayama Rosai Hospital, Okayama, Japan
Department of Pharmacy, Okayama Rosai Hospital, Okayama, Japan
Copyright © 2017 Yuki Morishita, Hiroaki Tanioka, Motoi Asano, Kotomi Tokuyama, Hiroko Okamoto, Tomohisa Okamoto, Takako Oda, Masatoshi Ohta, Masayuki Fukuzawa et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Morishita, Y. , Tanioka, H. , Asano, M. , Tokuyama, K. , Okamoto, H. , Okamoto, T. , Oda, T. , Ohta, M. and Fukuzawa, M. (2017) Clinical Predictors of Cetuximab for First-Line Therapy of Metastatic Colorectal Cancer: A Single Institutional Retrospective Study.
Journal of Cancer Therapy,
8, 827-837. doi:
10.4236/jct.2017.89072.